
This journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Kafkas Üniversitesi Veteriner Fakültesi Dergisi
2026 , Vol 32 , Issue 3
Estimation of Protective Dose 50 of Chromatographically Purified Foot and Mouth Disease Virus Serotype A, Asia 1 and O and Immune Response of Trivalent Vaccine in Bovines
1University of Veterinary and Animal Sciences, Faculty of Veterinary Sciences, Institute of Microbiology, 54000 Lahore, PAKISTAN2University of Veterinary and Animal Sciences, Faculty of Biosciences, Institute of Biochemistry and Biotechnology, 54000 Lahore, PAKISTAN DOI : 10.9775/kvfd.2026.36325 Foot and Mouth Disease (FMD) is an economically significant livestock disease in developing countries such as Pakistan, where serotypes A, Asia1, and O of Foot and Mouth Disease Virus (FMDV) are prevalent. Effective disease control relies on immunization using potent vaccines, and evaluation of vaccine potency in terms of protective dose 50 (PD₅₀) is a critical step during purified vaccine formulation. The present study aimed to prepare chromatographically purified vaccines of the three prevalent serotypes in different formulations and to determine PD₅₀ values. Viruses were propagated in cell culture, biologically titrated, and chemically inactivated. To obtain highly purified antigens with reduced non-structural protein content and improved quantification compared with conventional methods, viral antigens were purified, and quantified using Size Exclusion Chromatography (SEC) with Sephacryl S-300 followed by purity check through SDS-PAGE. Five formulations of each serotype (16, 8, 4, 2, and 1 μg/dose) were prepared and inoculated into five animals per concentration. Serum samples were analyzed by SPCE to identify protected animals. PD₅₀ values were calculated for each antigen and used to formulate a trivalent vaccine. The trivalent vaccine was evaluated for structural and non-structural proteins using SPCE and 3ABC ELISA, respectively. Results demonstrated that SEC efficiently removed NSPs, as confirmed by SDS-PAGE. PD₅₀ values for serotypes A, Asia1, and O were estimated as 2.14, 1.90, and 1.63 μg/dose, respectively. Accordingly, trivalent vaccine concentrations of 6.42, 5.70, and 4.90 μg/dose (3PD₅₀) were formulated. The trivalent purified vaccine induced protective immune responses with less than 20% NSP content in SPCE and 3ABC ELISA. Keywords : Size exclusion chromatography, Sephacryal S-300, SDS-PAGE, Nonstructural protein, PD50, Vaccine









